Tatva Chintan Pharma Chem share news, announcements and annual reports
NSE: TATVABSE: 543321Chemicals & PetrochemicalsSmall Cap
Share price at the NSE close on 2 Nov 2026. Previous close ₹1,643.90.
2 Nov: open ₹1,645.00, high ₹1,691.90, low ₹1,579.10
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹3,887 Cr999th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 61.78
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 4.77
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.12%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 8.0%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 8.8%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Sep 2026.
- 0.21
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 58,16834.6% delivered
Tatva Chintan Pharma Chem share news and announcements
329 announcements, routine notices left out, newest first. Page 6 of 7.
Jul 2022
6 Jul · Rating
Jun 2022
27 Jun · Analysts
May 2022
27 May · Analysts
25 May · Analysts
20 May · Related Party Transaction
7 May · Analysts
Apr 2022
30 Apr · Business
30 Apr · General updates
25 Apr · Dividend
25 Apr · Business
25 Apr · Results
22 Apr · Analysts
7 Apr · Analysts
2 Apr · Analysts
Mar 2022
28 Mar · Analysts
23 Mar · Analysts
7 Mar · Analysts
4 Mar · Analysts
3 Mar · Analysts
1 Mar · Analysts
Feb 2022
24 Feb · Analysts
1 Feb · Updates
Jan 2022
27 Jan · Analysts
20 Jan · Business
17 Jan · Results
17 Jan · Limited Review Report
17 Jan · Board meeting
15 Jan · Analysts
7 Jan · Board meeting
Dec 2021
24 Dec · Analysts
24 Dec · Analysts
Nov 2021
29 Nov · Analysts
13 Nov · Analysts